Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

New Eli Lilly Drug Retatrutide Brought Major Weight Loss in Trial

The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug.

Gina Kolata
Author: Gina Kolata

Written by

Gina Kolata

in

Clinical Trials, Eli Lilly and Company, GLP-1 RAs (Drug), Knees, Obesity, Research, Retatrutide
←Watch Lauren Boebert Haggle With Bouncer At George Santos’ Christmas Party
Why Oracle Is Worrying Investors About the A.I. Boom→

More posts

  • Paramount settles lawsuit with US states, helping clear way for $110bn merger with Warner Bros

  • Rosie O’Donnell Claims That ABC Wouldn’t Let Her Air An Epstein Survivors Segment When She Hosted “Jimmy Kimmel Live!”

  • Paramount Shares Fall After Antitrust Deal, But Wall Streeters Marvel At Favorable Terms

  • Donald Trump Vows To Appeal Ruling In Networks’ White House Ban Lawsuit, Even Though Judge Has Yet To Rule

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube